Source: Annual Congress 2012 - COPD beyond tobacco
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Apte, M. Barne, B. Brashier, S. Madas, J. Gogtay, S. Chhowala, B. Pachisia, S. Salvi (Pune, Mumbai, India). Presence of hypertension (HT), ischemic heart diseases (IHD) and a family history of hypertension are independently associated with reduced peak expiratory flow (PEF) values. Eur Respir J 2012; 40: Suppl. 56, 4010

Member's Comments

No comment yet.

Related content which might interest you: Increased prevalence of obstructive airways disease (OAD) in patients with ischemic heart disease (IHD) and hypertension (HT) Source: Eur Respir J 2007; 30: Suppl. 51, 122s Year: 2007 Non-invasive parameters can predict out of proportion pulmonary hypertension (PH) in conjunction with heart failure and preserved systolic function (HFPSF) in patients with moderate to severe PH Source: Annual Congress 2010 - Pulmonary hypertension updates Year: 2010 Usefulness of differential blood gas exchange assessment in patients with severe pulmonary arterial hypertension (PAH) associated to congenital heart disease (CHD) Source: Eur Respir J 2005; 26: Suppl. 49, 351s Year: 2005 Initial experience of sildenafil in patients with congenital heart disease (CHD) associated pulmonary arterial hypertension (PAH) Source: Eur Respir J 2006; 28: Suppl. 50, 425s Year: 2006 Arterial hypertension (AH) and endothelial function (EF) in patients with COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Minute ventilation (V‘E) and heart rate (HR) relationship during exercise in chronic cardiac and pulmonary diseases Source: Annual Congress 2012 - Exercise capacity: from elite athletes to severe impairment Year: 2012 The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care Source: Eur Respir J 2002; 20: Suppl. 38, 397s Year: 2002 Comparison between presence of respiratory symptoms and peak expiratory flow (PEF) values <80% predicted as screening tools for obstructive airways diseases (OAD) Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases Year: 2011 Mean pulmonary artery pressure-heart rate (mPAP-HR) relationship during submaximal supine exercise in idiopathic pulmonary arterial hypertension (iPAH) Source: Annual Congress 2005 - Exercise in pulmonary hypertension Year: 2005 The influence of diabetes type 2 (D2) on pulmonary hypertension (PH) in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 60s Year: 2005 Smoking history and pulmonary arterial hypertension (PAH) onset and clinical outcomes (REVEAL) Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Risk stratification of pulmonary arterial hypertension (PAH) associated with adult congenital heart disease (ACHD) Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 The composite physiological index strongly predicts mortality in interstitial lung disease (ILD) associated pulmonary hypertension (PH-ILD) Source: International Congress 2017 – Imaging and lung disease PH Year: 2017 Right heart volume load response in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 Pulse wave velocity (PWV) in patients (pts) with moderate COPD and cardiovascular risk: The effect of an inhaled long-acting β2-agonist/corticosteroid (SUMMIT) Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016 Decreased fractal dimension of heart rate dynamics in patients with COPD Source: Annual Congress 2006 - COPD comorbidity Year: 2006 Under pressure: pulmonary hypertension associated with left heart disease Source: Eur Respir Rev 2015; 24: 665-673 Year: 2015 Treatment with corticosteroids and yearly decline of forced expiratory flow (FEV1) in patients with severe chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Respiratory structure and function Year: 2008 Mismatch of major vessel obstruction and pulmonary vascular resistance (PVR) in chronic thromboembolic pulmonary hypertension (CTEPH) with associated medical conditions (AMC) Source: Eur Respir J 2006; 28: Suppl. 50, 402s Year: 2006 Pulmonary arterial hypertension (PAH) among end state renal disease (ESRD) patients under chronic hemodyalisis (HD) Source: Eur Respir J 2007; 30: Suppl. 51, 345s Year: 2007